stockrowHarvard Bioscience, Inc. (HBIO) vs Stereotaxis Inc. (STXS)
- Harvard Bioscience, Inc. HBIO 8.45 −0.12%
- Stereotaxis Inc. STXS 1.02 −2.86%
Harvard Bioscience, Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $105.2M against $38.5M — 2.7× the size. Harvard Bioscience, Inc. grew revenue faster over the last twelve months: −1.06% against −5.46%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −78.5%) and the higher return on invested capital (−0.41% vs −203.6%). Across the 18 metrics below, Harvard Bioscience, Inc. leads on 13 and Stereotaxis Inc. on 5.
Valuation
Profitability
| Metric | HBIO | STXS | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 58.16% | 55.57% | 53.60% |
| Operating margin | (0.28%) | (75.68%) | 1.97% |
| Net margin | (11.86%) | (78.45%) | 0.00% |
| Free cash flow margin | (2.09%) | (51.56%) | 2.36% |
| Return on equity | (89.95%) | (344.36%) | 0.00% |
| Return on assets | (13.32%) | (48.76%) | 0.00% |
| Return on invested capital | (0.41%) | (203.58%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack